Cite
HARVARD Citation
Day, J. et al. (n.d.). B.01 AVXS-101 gene-replacement therapy (GRT) for spinal muscular atrophy type 1 (SMA1): pivotal phase 3 study (STR1VE) update. Canadian journal of neurological sciences. p. S10. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Day, J. et al. (n.d.). B.01 AVXS-101 gene-replacement therapy (GRT) for spinal muscular atrophy type 1 (SMA1): pivotal phase 3 study (STR1VE) update. Canadian journal of neurological sciences. p. S10. [Online].